SOBRAFO Farmácia Oncológica

SOBRAFO Título de Especialista em Farmácia Oncológica (Brazil)

Farmacia Clinica OncologicaEnglish
Exam overview

Practice session

Why does concomitant administration of Proton Pump Inhibitors (PPIs, e.g., Omeprazole) or H2-Receptor Antagonists significantly decrease the oral bioavailability and clinical efficacy of oral Tyrosine Kinase Inhibitors (such as Erlotinib, Dasatinib, and Pazopanib)?

Loading your practice session…